Skip to content
OpenCapital
Get started

Lantern Pharma LTRN Q4 2025 Annual earnings

Reported March 30, 2026 · After market close

EPS-$0.36Beat by $0.10
EPS estimate-$0.46

Next report

Aug 12, 2026 (In 1 week)
EPS estimate-$0.38

Versus estimates

Revenue

Q4 2024$100.7K

Diluted EPS

Q1 2026-$0.30Beat by $0.06
Q4 2025-$0.36Beat by $0.10
Q3 2025-$0.39Beat by $0.07Q2 2025-$0.40Beat by $0.13Q1 2025-$0.42Beat by $0.07Q4 2024-$0.54Miss by $0.03

Ask the moment Lantern Pharma reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Lantern Pharma report Q4 2025 earnings?
Lantern Pharma (LTRN) reported Q4 2025 earnings on March 30, 2026 after market close.
What were Lantern Pharma's Q4 2025 revenue and EPS?
Lantern Pharma reported eps of $-0.36 for Q4 2025.
Did Lantern Pharma beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.46 by $0.10.
How did Lantern Pharma's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 33.3% from $-0.54.
Where can I find Lantern Pharma's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001493152-26-013608) and the 10-K periodic report (0001493152-26-013612) directly on SEC EDGAR. The filing index links above go to sec.gov.